Australia
Appendix 4C - Q2 FY23 Quarterly Cash Flow Report
Highlights: * Expanded participation in ATH434 Phase 2 clinical trial with sites opened for recruitment inAustralia, the United States, and Italy * Presented compelling bioMUSE data at two prestigious industry conferences * Granted a 20-year patent for 100 new compounds targeting Parkinson's...
2023-01-31 20:25
3668
Minviro completes successful capital raise of £2,100,000 and welcomes industry leading investors as new shareholders
Funds raised will be dedicated to helping Minviro expand into key markets, includingAsia, Australia and the Americas, and develop local operational presence to serve a rapidly growing global client base. LONDON, Jan. 26, 2023 /PRNewswire/ -- Minviro is a market leading sustainability consulting ...
2023-01-26 18:00
2683
Whispir announces a partnership with a leading flexible and integrated payment and engagement platform, Everyware®
MELBOURNE, Australia, Jan. 18, 2023 /PRNewswire/ -- Whispir Limited (ASX:WSP, Whispir or Company), a global communications intelligence company that supplies a no code, Communications-as-a-Service ("CaaS") platform, today announced its partnership with Everyware® to provide secure, reliable Pay b...
2023-01-18 21:53
3831
SEA Electric Partners with MEVCO to Electrify 8,500 Hilux and Landcruiser Models for Mining Industry
MELBOURNE, Austalia, Jan. 17, 2023 /PRNewswire/ -- SEA Electric has made the next step in its journey to electrify the world's commercial vehicle fleet, by signing a significant Memorandum of Understanding with MEVCO, a leading systems integrator focused exclusively on electric light commercial v...
2023-01-18 06:36
2243
Really Simple Systems Announces Collaboration Project with Rareloop
Global CRM software provider, Really Simple Systems, has announced a joint
project with software development agency, Rareloop, to build a mobile app
PETERSFIELD, England, Jan. 17, 2023 /PRNewswire/ -- Leading cloud software
vendor,Really Simple Systems
2023-01-17 18:00
2655
Denave unveils new visual identity
The new look reflects the company's dynamic approach and reaffirms commitment to growth NEW DELHI, Jan. 12, 2023 /PRNewswire/ -- Denave, a global technology-powered sales enablement enterprise, today announced a brand refresh including a new visual identity, redesigned logo and website, as part ...
2023-01-12 15:30
2430
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in the United States for the Treatment of Individuals with Multiple System Atrophy
U.S. now open for enrollment of rare, rapidly progressive Parkinsonian Disorder MELBOURNE, Australia and SAN FRANCISCO, Jan. 9, 2023 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying tre...
2023-01-09 23:25
2979
Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation)
MELBOURNE, Australia and SAN FRANCISCO, Jan. 6, 2023 /PRNewswire/ -- Alterity Therapeutics Limited ("Alterity" or the "Company") (ASX:ATH, NASDAQ:ATHE), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that its Board of D...
2023-01-06 20:25
4433
Alterity Therapeutics to Participate in the Sachs Associates 6th Annual Neuroscience Innovation Forum
MELBOURNE, Australia and SAN FRANCISCO, Jan. 3, 2023 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced thatDavid Stamler, M.D., ...
2023-01-03 23:25
2018
Alterity Therapeutics Announces Allowance of New Composition of Matter Patent by the United States Patent and Trademark Office
- Patent covers more than 100 novel compounds targeting neurodegenerative diseases including Parkinson's and Alzheimer's - MELBOURNE, Australia and SAN FRANCISCO, Dec. 29, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company d...
2022-12-29 23:25
3175
FDA agrees to Actinogen six-month Phase 2b Alzheimer's Disease trial
Exploring Xanamem® and the "cortisol hypothesis" for more than 6 million Americans suffering from Alzheimer's Disease[1] SYDNEY, Dec. 22, 2022 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) is pleased to announce receipt today of agreement from the US Food and Drug Administration (FDA) to...
2022-12-22 20:30
2478
Initial plan of development completed for Blue Star's world-class Las Animas helium project
PERTH, Australia, Dec. 19, 2022 /PRNewswire/ -- Blue Star Helium (ASX:BNL / OTCQB: BSNLF) (Blue Star or the Company) advises of the key outcomes from the Initial Plan of Development for its Las Animas Helium Project inColorado, USA. Highlights: Voyager – low capital intensity development of high...
2022-12-19 15:28
2472
Oracle Teams Up With OneQode to Deliver Low-Latency Solutions Across Asia-Pacific
SYDNEY, Dec. 15, 2022 /PRNewswire/ -- OneQode, Global Infrastructure-as-a-Service (IaaS) company, today announced it has joined Oracle PartnerNetwork (OPN). With OneQode now an OPN member, both companies will be able to provide enhanced offerings to enterprise customers in theAsia-Pacific region...
2022-12-15 22:00
2420
AustralianSuper and Churchill Asset Management announce new lending partnership
NEW YORK, Dec. 15, 2022 /PRNewswire/ -- AustralianSuper, Australia's largest superannuation (pension) fund, today announced a new partnership with Churchill Asset Management ('Churchill'), with an initial instalment of US$250 million, intended to grow substantially over time. The partnership will...
2022-12-15 20:00
2656
Actinogen announces first patient treated in depression and cognitive impairment Phase 2 clinical trial
Approximately 5% of Americans suffer from Major Depressive Disorder (MDD),[1] which is commonly associated with "foggy thinking" but a new clinical trial raises hope that once-a-day oral drug Xanamem® may assist where treatment by anti-depressant medication alone is inadequate SYDNEY, Dec. 14, 2...
2022-12-14 21:52
2382
Versius adopted for gynaecological and urogynaecological procedures at Frances Perry House
* Versius has been introduced at Frances Perry House, a private women's
hospital inMelbourne to offer patients access to the benefits of robotic
surgery for complex cases including hysterectomies CAMBRIDGE, England, Dec. 13,
2022 /PRNewswire/ -- CMR Surgical
2022-12-13 07:00
2880
Sapia.ai to invest in bringing the best kept secret in HR tech to America
From Australia, with love NEW YORK, Dec. 12, 2022 /PRNewswire/ -- Following its phenomenal success in transforming hiring for some ofAustralia's biggest retail brands, Sapia.ai is excited to grow its share of the US market in 2023 with the appointment of Russell Mikowski as President, Americas. ...
2022-12-12 22:00
2444
PharmAbcine Announces Collaboration Agreement with MSD to Evaluate Anti-VISTA Antibody PMC-309 in Combination with KEYTRUDA® (pembrolizumab)
DAEJEON, South Korea, Dec. 12, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the Company has entered into a clinical collaboration agreement with MSD (Merck & Co...
2022-12-12 21:00
2437
AETOS Capital Group Wins 2022 Best Forex Broker in Asia by Traders Awards
SYDNEY, Dec. 12, 2022 /PRNewswire/ -- AETOS Capital Group (AETOS) was awarded the Best Forex Broker inAsia 2022 by Traders Awards during the Traders Fair Ho Chi Minh Gala Night hosted by FINEXPO onDecember 10th, 2022. This year, over 288 financial companies were shortlisted for the award. The wi...
2022-12-12 12:13
2624
Cavendish Renewable Technology Signs Agreement for Development of State-of-the-Art Hydrogen Electrolyser Technologies with Adani New Industries Limited
Highlights * CRT is a technology partner for developing Green Hydrogen Electrolyser Technologies * Adani Group plan to invest USD $70 billion by 2030 in green technologies and projects * The next decade will be a golden era for hydrogen MELBOURNE, Australia, Dec. 8, 2022 /PRNewswire/ -- Ca...
2022-12-09 12:37
2193
Week's Top Stories
Most Reposted
Radisson Hotel Group accelerates growth in Indonesia with ANTA Hotel Bali Canggu, a member of Radisson Individuals
[Picked up by 313 media titles]
2025-12-10 10:00
ARKANCE to Launch BIMLOGIQ - A New AI-Powered Extension to Its AEC Tech Stack Offering
[Picked up by 293 media titles]
2025-12-11 09:07
Synvo AI and Sobat Bisnis Group (SBG) Forge Strategic Partnership to Bring Secure, Context-Aware Enterprise AI to Indonesia and Southeast Asia
[Picked up by 290 media titles]
2025-12-16 08:00
Colebrook Bosson Saunders Chooses India for First Executive Dialogue Exploring Future of Workspaces and Technology
[Picked up by 287 media titles]
2025-12-16 14:26
Tiiny AI Reveals World's Smallest Personal AI Supercomputer, Verified by Guinness World Records
[Picked up by 285 media titles]
2025-12-10 16:00
